000403.SZ
派林生物
SZSE · Healthcare · C 制造业 · CN
CNY 10.26
−3.48%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
26.5x
EV/EBITDA
15.0x
Market Cap
CNY 9.75B
MomentumView details →
1D Return
−3.48%
YTD Return
−24.40%
RSI (14)
47.0
ValuationView details →
P/E (Fwd)
26.5x
EV/EBITDA
15.0x
Market Cap
CNY 9.75B
RSI (14)
47.0
MomentumView details →
1D Return
−3.48%
YTD Return
−24.40%
Similar companies
Latest newsMore news →
Pailin Biologics reported its 2026 first-half results on August 23, with net profit attributable to shareholders down 64.25% year-on-year to 84.301 million yuan and revenue down 15.88% to 830 million yuan.12d agoPailin Biologics proposed a cash dividend of 1.5 yuan per 10 shares (tax included) for the first half of 2026.12d ago